PPARGC1A and chronic kidney disease: PGC-1α has been implicated in the pathophysiology of AKI, AKI-to-CKD transition, and CKD through its effects on oxidative phosphorylation, fatty acid beta oxidation, and mitochondrial biogenesis [16].